Skip to main content
Clinical Trials/KCT0003573
KCT0003573
Recruiting
未知

Product to predict the progression of diabetic nephropathy using urinary exosomal microRNA

Gachon University Gil Medical Center0 sites270 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Gachon University Gil Medical Center
Enrollment
270
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Type 2 diabetic patients diagnosed at the age of 30 or older
  • \- Aged 75 and younger
  • \- Patients with eGFR and albuminuria recordings at least three times in intervals of at least 3 months
  • \- Patients taking antihypertensive agents and angiotensin converting enzyme (ACE) inhibitor / angiotensin II receptor blocker (ARB) for hypertension or albuminuria have been receiving stable doses for more than 2 weeks
  • As a healthy healthy control group, adult subjects who aged more than 30 and 75 or less years old, with neither diabetes nor chronic kidney disease

Exclusion Criteria

  • ? Under the age of 30 or over 75 years old
  • ? Patients with type 1 diabetes or diabetic ketoacidosis
  • ? Patients with CKD unrelated to diabetes
  • ? Patients with poor blood pressure control or those taking 4 or more classes of antihypertensive drugs
  • ? Patients with kidney transplantation or single kidney, patients with genetic kidney disease
  • ? Among retrospective trajectory data, initial urine albumin/creation ratio (UACR)\> 3500 mg/g, hemoglobin \<11 g/dL, or serum albumin \<3\.6 g/dL
  • ? Hemoglobin A1c level\> 11\.0% at enrollment,
  • ? A history of dialysis or a history of acute kidney injury
  • ? Other severe systemic disease or BMI \<18\.5 kg /square meters
  • ? Pregnant women

Outcomes

Primary Outcomes

Not specified

Similar Trials